Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
FP05 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
-
+
FP05.02 - A Biomarker-Directed, Multi-Center Phase II Study of Molecular Response Adaptive Immuno-Chemotherapy in Lung Cancer
00:00 - 00:00 | Presenter: Valsamo Anagnostou
- Abstract
Loading...
-
+
FP07 - Mesothelioma, Thymoma and Other Thoracic Malignancies
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
-
+
FP07.05 - DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
00:00 - 00:00 | Presenter: Anna Nowak
- Abstract
Loading...
-
+
OA12 - Understanding and Augmenting Responses to Immunotherapy for Thoracic Malignancies
- 12:00 - 13:00
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Tumor Biology and Systems Biology: Basic and Translational Science
- Moderators:Valsamo Anagnostou
-
+
OA12.01 - Genomic and Immune Cell Landscape of Response to Chemo-Immunotherapy in Malignant Pleural Mesothelioma
12:00 - 12:10 | Presenter: Valsamo Anagnostou
- Abstract
Loading... -
+
OA12.02 - Metformin Has Divergent Effects on the Tumor Immune Microenvironment of Non-Small Cell Lung Cancer (NSCLC) Depending on Obesity
12:10 - 12:20 | Presenter: Joseph Barbi
- Abstract
Loading... -
+
OA12.03 - Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC
12:20 - 12:30 | Presenter: Shuai Li
- Abstract
Loading... -
+
OA12.04 - Pre-Treatment T-Cell Receptors (TCR) Repertoire in Non-Small Cell Lung Cancer (NSCLC) Patients Treated With Single Agent Immunotherapy
12:30 - 12:40 | Presenter: Afaf Abed
- Abstract
Loading... -
+
OA12.05 - Discussant
12:40 - 12:50 | Presenter: David Carbone
- Abstract
No abstract available for this presentation
-
+
OA12.06 - Live Discussion with Speakers
12:50 - 13:00
- Abstract
No abstract available for this presentation
